Company / EPS (Basic)
Envista Holdings EPS (Basic) History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$0.28
FY2025
5-year range
-$6.50 / $2.11
FY2021-FY2025
Trend
+104.3%
vs FY2024
Sector context
#93 of 160
Health Care
What the data says
At $0.28, Envista Holdings's eps (basic) ranks #93 of 160 in the Health Care sector. EPS (Basic) returned to growth in FY2025 after 3 years of decline, reaching $0.28.
Based on SEC 10-K filings.
0.28 in FY2025 with a 5-year CAGR of +5.9%.
Improved from $-0.60 to $0.28 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -42.7%
- 5-Year CAGR
- +5.9%
- 10-Year CAGR
- -
Sector benchmark
#93 of 160 in Health CareTop 58% of 160This company $0.28 Sector average $2.36
▼
-88.2% below sector average
Key checks
Key Insights
- In FY2025, eps (basic) increased 104.3% year-over-year.
- Ranks #93 out of 160 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2019.
- Lowest eps (basic) in the period was in FY2024.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.28 | +104.3% |
| FY2024 | -$6.50 | -983.3% |
| FY2023 | -$0.60 | -140.3% |
| FY2022 | $1.49 | -29.4% |
| FY2021 | $2.11 | +904.8% |
| FY2020 | $0.21 | -91.1% |
| FY2019 | $2.35 | +30.6% |
| FY2018 | $1.80 | -23.4% |
| FY2017 | $2.35 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026